Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$122,875,000
New position
Shares Held
125,000,000
first reported quarter
Ownership
130.7%
of shares outstanding
% of Portfolio
2.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $219,279,875 across 4 Diagnostics & Research names.
All Filings in MYGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,875,000 | 125,000,000 | Principal | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||